Concepedia

Michael Mitterer

MM

Statistics

Publications

10

Citations

630

H-Index

10

Active since

1999

Affiliations

Max Planck Institute of Immunobiology and Epigenetics(Current)

University of Freiburg

Sidney Kimmel Comprehensive Cancer Center

Heidelberg University

Bloomberg (United States)

Michael Mitterer is an author at Max Planck Institute of Immunobiology and Epigenetics specializing in life sciences, biochemistry, and metabolomics.

Publications per year

1999–2025

10

Publications

10

Abnormal Development and Function of B Lymphocytes in Mice Deficient for the Signaling Adaptor Protein SLP-65

Hassan Jumaa, Bernd Wollscheid, Michael Mitterer et al. · Immunity · 1999 · 317 citations · Full text

, , +17

Multilayer omics analysis reveals a non-classical retinoic acid signaling axis that regulates hematopoietic stem cell identity

Katharina Schönberger, Nadine Obier, Mari Carmen Romero-Mulero et al. · Cell stem cell · 2021 · 89 citations · Full text

, , +16

The absence of SLP65 and Btk blocks B cell development at the preB cell receptor-positive stage

Hassan Jumaa, Michael Mitterer, Michael Reth et al. · European Journal of Immunology · 2001 · 62 citations · Full text

, , +14

Phosphoinositide acyl chain saturation drives CD8+ effector T cell signaling and function

Joy Edwards-Hicks, Petya Apostolova, Joerg M. Buescher et al. · Nature Immunology · 2023 · 38 citations · Full text

, , +14

LC-MS-Based Targeted Metabolomics for FACS-Purified Rare Cells

Katharina Schönberger, Michael Mitterer, Katharina M. Glaser et al. · Analytical Chemistry · 2023 · 31 citations · Full text

, , +17

1–5 of 10